Moderna

Market Access

Moderna’s missteps spotlight PMCPA’s role in upholding pharm...

The pharmaceutical industry operates under a complex regulatory landscape, balancing government oversight with self-imposed standards.

News

vaccine vial held by hands in surgical green gloves

MSD, Moderna start phase 3 adjuvant lung cancer trial

MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-sta

News

WhatsApp lands Moderna in hot water with PMCPA

A WhatsApp message has earned Moderna a reprimand from the UK's Prescription Medicines Code of Practice Authority (PMCPA), with Novo Nordisk, Otsuka, AstraZeneca, and Daiichi Sankyo also fo

News

GSK turns its guns on Moderna in mRNA jab patent dispute

GSK has filed a pair of lawsuits against Moderna, claiming infringement of patents covering mRNA vaccines for COVID-19 and respiratory syncytial virus (RSV).

News

Moderna will cut $1.1bn off its annual R&D spend

Moderna is showcasing its R&D pipeline to investors today, but the headline news is a decision to cut its R&D spend by a massive $1.1 billion a year from 2027, reversing years of gr

News

Herpes simplex virus (HSV-2) capsid visualisation

GSK drops HSV jab, leaving rival mRNA shots in pole position

GSK has abandoned its clinical-stage vaccine for herpes simplex virus (HSV) after a disappointing phase 1/2 trial, ceding the ground to mRNA shots in development at Moderna and BioNTech.

Moderna’s missteps spotlight PMCPA’s role in upholding pharm...

MSD, Moderna start phase 3 adjuvant lung cancer trial

WhatsApp lands Moderna in hot water with PMCPA

GSK turns its guns on Moderna in mRNA jab patent dispute

Moderna will cut $1.1bn off its annual R&D spend

GSK drops HSV jab, leaving rival mRNA shots in pole position

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

Moderna

Editor's Picks